McDermott, D. F., Peer, A., Gurney, H., Khan, A., Neiman, V., Tamjid, B., Trujillo, J. A., Moujaber, T., Dresler, H., Maughan, B. L., Cornell, J., Perini, R. F., Rana, A., Atkins, M. B. (2026). Ascending dose escalation of belzutifan plus palbociclib for previously treated advanced clear cell renal cell carcinoma (ccRCC): Phase 1/2 LITESPARK-024 study part 1.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.423